Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDirecta Plus Regulatory News (DCTA)

  • This share is currently suspended. It was suspended at a price of 6.75
  • There is currently no data for DCTA

Total Voting Rights

27 Jul 2020 16:46

RNS Number : 2155U
Directa Plus PLC
27 July 2020
ย 

27 July 2020

ย 

Directa Plus plc

("Directa Plus" or the "Company")

ย 

Total Voting Rights

ย 

Directa Plus (AIM: DCTA) announces that the Company's issued share capital comprises 61,174,587 Ordinary Shares and the total number of voting rights in the Company is 61,174,587. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority.

ย 

Further to the exercise of share options announced in early July, the Company realised that it was necessary to apply for the admission to trading on AIM of 1 additional new ordinary share ("Admission"). This additional share is included in the issued capital detailed above. Such application has been made to the London Stock Exchange and it is expected that Admission will become effective at 8.00 a.m. on 31 July 2020.

ย 

For further information please visit http://www.directa-plus.com/ or contact:

ย 

Directa Plus plc

+39 02 36714458

Giulio Cesareo, CEO

ย 

Marco Ferrari, CFO

ย 

ย 

ย 

Cantor Fitzgerald Europe (Nominated Adviser and Joint Broker)

+44 20 7894 7000

Rick Thompson, Philip Davies, Will Goode (Corporate Finance)

ย 

ย 

ย 

N+1 Singer (Joint Broker)

+44 20 7496 3069

Mark Taylor

ย 

ย 

ย 

Tavistock (Financial PR and IR)

+44 20 7920 3150

Simon Hudson, Edward Lee

ย 

ย 

About Directa Plus

Our focus is principally on the two sectors in which we have strong commercial advantage through developed and launched products and a technological lead: environmental (based on our Grafysorberยฎ product) and textiles (based on our G+ยฎ products). In addition, we will continue to pursue opportunities in elastomers and composites (including tyres and asphalt), also using our G+ยฎ products. All our products are hypoallergenic, non-toxic and sustainably produced.

ย 

-ends-

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
ย 
END
ย 
ย 
TVREDLFLBDLZBBX
Date   Source Headline
23rd Nov 20202:06 pmRNSSecond Price Monitoring Extn
23rd Nov 20202:01 pmRNSPrice Monitoring Extension
23rd Nov 202011:05 amRNSSecond Price Monitoring Extn
23rd Nov 202011:00 amRNSPrice Monitoring Extension
23rd Nov 20209:05 amRNSSecond Price Monitoring Extn
23rd Nov 20209:00 amRNSPrice Monitoring Extension
23rd Nov 20207:00 amRNSUpdate on Partner NexTech Batteries
17th Nov 20207:00 amRNSGrant of Options
26th Oct 20207:00 amRNSGraphene for Use in Lithium Sulphur Batteries
14th Oct 20207:00 amRNSSetcar Update
24th Sep 20207:00 amRNSHalf-year Report
9th Sep 20207:00 amRNSPublication of Scientific Paper
13th Aug 20207:00 amRNSCo-Mask Anti-Viral (COVID-19) Properties Confirmed
10th Aug 20207:00 amRNSAgreement with Poltrona Frau
4th Aug 20207:00 amRNSNew San Giorgio Bridge Opens with Gipave Asphalt
30th Jul 20207:00 amRNSItalian Patent Grant for Shoe Outsoles
29th Jul 20209:00 amRNSPrice Monitoring Extension
29th Jul 20207:00 amRNSAgreement with Italdesign
28th Jul 20207:00 amRNSAppointment of Nominated Adviser and Joint Broker
27th Jul 20204:46 pmRNSTotal Voting Rights
13th Jul 20207:00 amRNSAward of Waste Management Contract
1st Jul 202011:57 amRNSDirector/PDMR Shareholding
30th Jun 20207:00 amRNSDirector/PDMR Shareholding
26th Jun 202012:56 pmRNSResult of AGM
25th Jun 20207:00 amRNSGipave graphene asphalt trial in Kent
23rd Jun 202010:21 amRNSDirector/PDMR Shareholding
22nd Jun 20207:00 amRNSGrant of Chinese Patent
19th Jun 20207:00 amRNSLaunch of Co-Mask
1st Jun 20205:30 pmRNSPosting of Annual Report & Notice of AGM
26th May 20207:00 amRNSGrant of Key Textile Patent
21st May 20207:00 amRNSFinal Results
18th May 20207:00 amRNSTechnology Innovation Award from Frost & Sullivan
27th Apr 20207:00 amRNSEuropean Patent Grant
14th Apr 20202:06 pmRNSSecond Price Monitoring Extn
14th Apr 20202:01 pmRNSPrice Monitoring Extension
14th Apr 20207:00 amRNSAgreement with Iterchimica
30th Mar 20202:05 pmRNSSecond Price Monitoring Extn
30th Mar 20202:00 pmRNSPrice Monitoring Extension
23rd Mar 20207:00 amRNSCovid-19 Update
13th Mar 20207:00 amRNSTrading Update
12th Feb 20207:00 amRNSEco certification of graphene printing technology
3rd Feb 20207:00 amRNSAward of Environmental services contract
27th Jan 20207:00 amRNSEU Grant for Eco-friendly G+ Printing Technology
20th Jan 20207:00 amRNSR&D Agreement with Comerio Ercole
9th Dec 20197:00 amRNSAward of Environmental Services Contract
26th Nov 20197:00 amRNSCompletion of Acquisition
8th Nov 20197:00 amRNSUK road trial of graphene enhanced asphalt
25th Oct 20195:46 pmRNSHolding(s) in Company
25th Oct 20199:00 amRNSHolding(s) in Company
23rd Oct 20195:20 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.